Your browser doesn't support javascript.
loading
Asymmetric Ruthenium-Catalyzed C-H Activation by a Versatile Chiral-Amide-Directing Strategy.
Chen, Wenkun; Jiang, Jijun; Wang, Jun.
Afiliação
  • Chen W; School of Chemistry, Key Laboratory of Bioinorganic and Synthetic Chemistry of Ministry of Education, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, Sun Yat-Sen University, 510006, Guangzhou, P. R. China.
  • Jiang J; School of Chemistry, Key Laboratory of Bioinorganic and Synthetic Chemistry of Ministry of Education, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, Sun Yat-Sen University, 510006, Guangzhou, P. R. China.
  • Wang J; School of Chemistry, Key Laboratory of Bioinorganic and Synthetic Chemistry of Ministry of Education, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, Sun Yat-Sen University, 510006, Guangzhou, P. R. China.
Angew Chem Int Ed Engl ; 63(6): e202316741, 2024 Feb 05.
Article em En | MEDLINE | ID: mdl-38102747
ABSTRACT
A versatile and readily available chiral amide directing group has been developed for the ruthenium(II)-catalyzed asymmetric C-H activation. Asymmetric C-H activation of the related chiral benzamides with various olefins, aldehydes and propargylic alcohols has been accomplished with high stereoselectivities, affording a series of chiral products including 3,4-dihydroisocoumarins (up to 96 % ee), isocoumarins (up to 92 % ee), phthalides (up to 99 % ee), chiral bicyclo[2.2.1]heptanes (>20 1 dr), 4-alkylidene-3,4-dihydroisocoumarins (up to 97 % ee) and allenes (>20 1 dr). Importantly, our methodologies enabled concise syntheses of many biologically active compounds and natural products (e.g., Montroumarin, Cyclosporone E, Cyclosporone Q, Concentricolide, Chuangxinol, and Eleutherol).
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article